IRIN HIV/AIDS Weekly - 268: 27-Jan-06

IRIN HIV/AIDS Weekly - 268 Africa 27 January 2006

NEWS: AFRICA: Uninterrupted ART vital to longevity - new study SOUTH AFRICA: Concern as MSF starts handover of HIV/AIDS treatment ZIMBABWE: More children abused as situation worsens NAMIBIA: Poor access to treatment hampers fight against TB ZAMBIA: Promising new combination therapy reduces MTCT SWAZILAND: Campaign to inform women of their legal rights underway EVENTS 1. Behaviour Change Communication Training Course 2. MSM at AIDS2006 JOBS 1. Global Fund recruiting experts to serve on the Technical Review Panel (TRP) NEWS AFRICA: Uninterrupted ART vital to longevity - new study Staying on antiretroviral therapy (ART) to keep viral loads low is better than taking structured breaks from the drugs, a study by the US's National Institute for Allergy and Infectious Diseases (NIAID) has revealed. Treatment interruptions became a topic of much debate amongst HIV researchers after a handful of people who had previously taken anti-AIDS treatment maintained very low levels of viral load, even when they stopped their treatment. Although antiretroviral medication improves the chances of living longer, the side effects and costs of the complex life-long regimes and the threat of drug resistance with long-term use has made doctors and patients look for alternative ways of using them, especially in developing countries. More details: http://www.plusnews.org/AIDSreport.asp?ReportID=5632 SOUTH AFRICA: Concern as MSF starts handover of HIV/AIDS treatment After five years of groundbreaking work in the treatment of HIV/AIDS, medical humanitarian agency Medecins Sans Frontiers (MSF) are preparing to pull out of their most successful South African programme. They began offering antiretroviral therapy (ART) in the poverty stricken Cape Town township of Khayelitsha in 2001, when the provision of anti-AIDS drugs in the public sector was still illegal. The South African government deemed the rollout too complex and expensive to implement. "Doctors within MSF were frustrated by the positive impact antiretroviral therapy (ART) was having elsewhere, while thousands continued to die prematurely in South Africa," explained Dr Eric Goemaere, head of mission for MSF South Africa. More details: http://www.plusnews.org/AIDSreport.asp?ReportID=5631 ZIMBABWE: More children abused as situation worsens The worsening humanitarian situation in Zimbabwe is making children more vulnerable to abuse, according to child rights NGOs. "For instance, because of the hike in school fees many children are visiting schools [trying to negotiate payment] - it makes them more vulnerable at the hands of teachers who exploit them," said Witness Chikoko, acting director of the African Network for the Prevention and Protection Against Child Abuse and Neglect. Staff at a boarding primary school near Marondera outside the capital, Harare, were recently charged with abusing 52 girls, while 14 primary school girls were also allegedly abused by staff members at a school in the capital. More details: http://www.plusnews.org/AIDSreport.asp?ReportID=5629 NAMIBIA: Poor access to treatment hampers fight against TB Despite its status as a middle-income country, Namibia has a high incidence of tuberculosis (TB), a poverty-related disease. Poor geographical access to health services has hampered the treatment rate of TB, the country's second biggest killer, said Alfons Babie, an official at the recently created directorate for special diseases in the health ministry. Instead of the international target of 85 percent stipulated by the World Health Organisation (WHO), the TB treatment rate in Namibia is only 64 percent. More details: http://www.plusnews.org/AIDSreport.asp?ReportID=5636 ZAMBIA: Promising new combination therapy reduces MTCT Zambia's government has begun using a new drug in its prevention of mother-to-child transmission (PMTCT) programme, in an effort to reduce drug resistance in both mother and infant. Dr Miriam Chipimo, reproductive health specialist at the Central Board of Health (CBoH), told PlusNews that Nevirapine was now being used in combination with the anti-AIDS drug, Zidovudine, also known as AZT. Although a single dose of Nevirapine reduces the rate of HIV transmission, scientists have found that a combination of antiretrovirals (ARVs) can result in lower rates of Nevirapine resistance. More details: http://www.plusnews.org/AIDSreport.asp?ReportID=5637 SWAZILAND: Campaign to inform women of their legal rights underway The Swaziland branch of Women in Law in Southern Africa has launched an awareness campaign to teach HIV-positive women about their legal rights. "There are three issues: acquainting HIV-positive women with their protection under existing laws, finding legal representation for women when they have a case to make and, finally, changing antiquated laws that need to be reformed to take into consideration gender rights and AIDS," president of the women's law society, Lomcebo Dlamini, told PlusNews in an interview. In a country that only elevated the legal status of women from minors to adults at the beginning of 2006, where the estimated HIV prevalence is 40 percent and widespread stigma and discrimination are ongoing problems, few have turned to the legal system for relief. More details: http://www.plusnews.org/AIDSreport.asp?ReportID=5641 EVENTS The Centre for African Family Studies (CAFS) will be holding a training course on the 'Advances in Behaviour Change Communication for HIV/AIDS' in Nairobi, Kenya, from 17 July to 4 August 2006. This is an intensive three-week learning opportunity for programme managers, health educators, programme officers, and donor agency field staff. Facilitated by international behaviour change communication experts, participants in this course are guided to explore and understand the elements of effective behaviour change communication in HIV/AIDS programmes, with particular emphasis on how to motivate people to initiate and sustain behaviour change. The tuition fee is US $2,800 for the three-week course, which covers tuition, training materials, supplies, training-related field trips and certification awards. For more information visit the CAFS website www.cafs.org or contact The Director, Centre for African Family Studies, Pamstech House, Woodvale Grove, Westlands P.O. Box 60054 00200, Nairobi, Kenya. Fax: +254 20 4448621 Email: courses@cafs.org 2. In August 2006, 20,000 researchers, activists, community workers and people living with HIV/AIDS from around the world will descend upon Toronto, Canada, for the XVI International AIDS Conference. In the days leading up to the conference, the AIDS Committee of Toronto (ACT) and partner organisations from across Canada and other parts of the world will host an affiliated event on issues affecting gay, bisexual and other men who have sex with men (MSM) and the organisations that work with them. The two-day event, confirmed for 10-11 August, will bring together AIDS and human rights organisations from developing and industrialised countries, in the hope of establishing long-term, far-reaching networks that bridge continents, cultures and issues. The draft goal and objectives of the event are as follows: Goal: To support ongoing connections between individuals and organisations working with gay, bisexual and other men who have sex with men (MSM) in the area of HIV/AIDS. Objectives: 1. Provide opportunities for dialogue on issues related to HIV/AIDS and gay, bisexual and other MSM 2. Facilitate discussions of HIV prevention for gay, bisexual and other MSM 3. Highlight emerging issues and responses related to gay men and HIV/AIDS 4. Discuss ways to advance the leadership of gay, bisexual and other MSM in the HIV/AIDS pandemic For more information, and feedback on the goal and objectives of the event, please contact: Rick Marchand Community Based Research Centre Vancouver, Canada Email: rmarchand@telus.net rmarchand@telus.net Deadline for input: 7 February 2006 JOBS The Global Fund to Fight AIDS, Tuberculosis and Malaria is recruiting experts to serve on the Technical Review Panel (TRP). The TRP, which has 26 members, plays a crucial role in reviewing proposals submitted to the Global Fund and ensuring that those funded are of high quality. Individuals with expert technical knowledge and extensive experience in one of the following are sought: - HIV/AIDS - Tuberculosis - Malaria - Crosscutting issues (such as institutional and governance issues, macro-economics in a health sector context) The current term of appointment is four rounds of proposals. TRP members must be available for the two-week TRP meetings in Geneva every 12 months. In addition, TRP members need to be accessible by email for up to six months for the clarification process for the proposals approved by the Board. Fluency in English is required, as this is the working language of the TRP. A transparent criteria-based selection process will be followed, which seeks to achieve a significant proportion of members from each of the WHO regions, and representation from public and private sectors and civil society, including a qualified member from the Persons Living with AIDS, Tuberculosis and/or Malaria community. A balanced gender representation is sought. Applicants from the private sector with extensive experience are strongly encouraged. The private-sector experience need not be limited to the pharmaceutical industry: experience in managing private health systems or healthcare in the developing world would be very useful. Individuals with expertise in HIV/AIDS and/or crosscutting issues, who also have specific nutritional expertise, are also encouraged to apply. Moreover, short-listed candidates will be used as the source for new TRP members for the next two rounds. For more details and to download an Application Form, please visit the Global Fund website: www.theglobalfund.org Or download the Form from HLSP's website: www.hlsp.org/workingwithus/globalfund Completed application forms should be sent to: globalfund.trp@hlsp.org to arrive no later than Friday 3 March 2006. Applicants without Internet access should contact the local WHO or UNAIDS office for assistance. IRIN-SA Tel: +27 11 895-1900 Fax: +27 11 784-6759 Email: IRIN-SA@irin.org.za - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - Appropriate Donations for International Disaster/Humanitarian Needs - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - Center for International web: www.cidi.org Disaster Information listserv: www.cidi.org/listsub.htm guidelines: www.cidi.org/donate.htm - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - HIV-AIDS Weekly Issue www.cidi.org/humanitarian/hivaids